Literature DB >> 32329879

An alternative approach to minimize the risk of coronavirus (Covid-19) and similar infections.

A Ahmad1, M U Rehman, K M Alkharfy.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new strain that was discovered in 2019 and has not been previously identified in humans. On December 31st 2019 World Health Organization (WHO) was informed of a cluster of cases with pneumonia of unknown origin from Wuhan City, Hubei province of China. The WHO announced in February 2020 that COVID-19 is the official name of the coronavirus diseases. A total of 519,899 confirmed cases with 23,592 deaths linked to this pathogen as on March 27, 2020 have been reported. Due to increasing number of infected people across the continents and huge loss to human life, the WHO has declared the novel COVID-19 outbreak a pandemic. A pandemic is defined as the "worldwide spread" of a new disease. Currently, no COVID-19 specific treatments have been approved by the United States Food and Drug Administration (US-FDA). However, the current treatment options include hydroxychloroquine, tocilizumab, remdesivir, lopinavir-ritonavir (Kaletra®), and nitazoxanide. In recent past, some natural herbal compounds have demonstrated encouraging anti-viral properties. This article attempted to summarize available information on the reported anti-viral activity of some natural products.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32329879     DOI: 10.26355/eurrev_202004_20873

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  10 in total

Review 1.  Natural products' role against COVID-19.

Authors:  Ananda da Silva Antonio; Larissa Silveira Moreira Wiedemann; Valdir Florêncio Veiga-Junior
Journal:  RSC Adv       Date:  2020-06-19       Impact factor: 4.036

Review 2.  The Current Recommended Drugs and Strategies for the Treatment of Coronavirus Disease (COVID-19).

Authors:  Mojgan Sheikhpour
Journal:  Ther Clin Risk Manag       Date:  2020-10-07       Impact factor: 2.423

Review 3.  The potential of glycyrrhizin and licorice extract in combating COVID-19 and associated conditions.

Authors:  Adel A Gomaa; Yasmin A Abdel-Wadood
Journal:  Phytomed Plus       Date:  2021-02-17

4.  Plant-Derived Food Grade Substances (PDFGS) Active Against Respiratory Viruses: A Systematic Review of Non-clinical Studies.

Authors:  Francis U Umeoguaju; Benson C Ephraim-Emmanuel; Kingsley C Patrick-Iwuanyanwu; Judith T Zelikoff; Orish Ebere Orisakwe
Journal:  Front Nutr       Date:  2021-02-09

Review 5.  The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment.

Authors:  Esmé Jansen van Vuren; Stephan F Steyn; Christiaan B Brink; Marisa Möller; Francois P Viljoen; Brian H Harvey
Journal:  Biomed Pharmacother       Date:  2021-01-01       Impact factor: 6.529

Review 6.  Efficacy of tocilizumab in the treatment of COVID-19: An umbrella review.

Authors:  Mohammad Mahdi Rezaei Tolzali; Maryam Noori; Pourya Shokri; Shayan Rahmani; Shokoufeh Khanzadeh; Seyed Aria Nejadghaderi; Asra Fazlollahi; Mark J M Sullman; Kuljit Singh; Ali-Asghar Kolahi; Shahnam Arshi; Saeid Safiri
Journal:  Rev Med Virol       Date:  2022-08-27       Impact factor: 11.043

7.  Potential mechanism underlying the effect of matrine on COVID-19 patients revealed through network pharmacological approaches and molecular docking analysis.

Authors:  Wenpan Peng; Yong Xu; Di Han; Fanchao Feng; Zhichao Wang; Cheng Gu; Xianmei Zhou; Qi Wu
Journal:  Arch Physiol Biochem       Date:  2020-09-11       Impact factor: 4.076

8.  Lessons learned from COVID-19 pandemic in Italy - A commentary.

Authors:  Antonio Minni; Massimo Ralli; Francesca Candelori; Fabrizio Cialente; Lucia Ercoli; Claudio Parlapiano; Antonio Greco; Marco De Vincentiis
Journal:  Bosn J Basic Med Sci       Date:  2021-02-01       Impact factor: 3.363

9.  Akt-independent effects of triciribine on ACE2 expression in human lung epithelial cells: Potential benefits in restricting SARS-CoV2 infection.

Authors:  Mir S Adil; Arti Verma; Madhuri Rudraraju; S Priya Narayanan; Payaningal R Somanath
Journal:  J Cell Physiol       Date:  2021-02-24       Impact factor: 6.513

10.  Can children's oral hygiene and sleep routines be compromised during the COVID-19 pandemic?

Authors:  Ana Sofia Baptista; Ivana Meyer Prado; Matheus França Perazzo; Teresa Pinho; Saul Martins Paiva; Isabela Almeida Pordeus; Júnia Maria Serra-Negra
Journal:  Int J Paediatr Dent       Date:  2020-10-13       Impact factor: 3.264

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.